Meditor Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-1,050,000	Closed	-$11.9M	–	19
2013 Q3	$11.9M	Buy	1,050,000 +780,000	+289%	+$8.83M	1.68%	23
2013 Q2	$3.61M	Buy	+270,000	New	+$3.61M	0.49%	29